Skip to main
ATXS
ATXS logo

Astria Therapeutics (ATXS) Market Capitalization Overview

Market Cap: $334.66M as of Jun 16, 2025

$334.66M
Past Month+$109.49M (48.62%)
As of Jun 16, 2025, Astria Therapeutics (ATXS) has a market capitalization of $334.66M. Over the past 30 days, its market cap has decreased by -7.36%, while in the last 12 months, it has decreased by -33.67%.

Market capitalization represents the total value of Astria Therapeutics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

Astria Therapeutics (ATXS) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of Astria Therapeutics (ATXS) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Astria Therapeutics (ATXS) Market Cap History

DateMarket CapChange
Jun 2, 2025$269.76M-7.36%
May 1, 2025$291.21M-4.44%
Apr 1, 2025$304.75M-11.48%
Mar 3, 2025$344.25M-17.90%
Feb 3, 2025$419.31M-17.17%
Jan 2, 2025$506.22M-13.50%

Astria Therapeutics (ATXS) End of Year Market Cap History

DateMarket CapChange
2025$334.66M-33.67%
2024$504.53M+80.99%
2023$278.76M+9.79%
2022$253.90M+262.08%
2021$70.13M+63.15%
2020$42.99M

FAQs About Astria Therapeutics (ATXS) Market Cap

As of Jun 16, 2025, the market capitalization of Astria Therapeutics (ATXS) is $334.66M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Astria Therapeutics’s market capitalization has increased by 48.62%, changing from $225.18M to $334.66M as of Jun 16, 2025.

In the last 3 months, Astria Therapeutics’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, Astria Therapeutics’s market capitalization increased from $278.76M in January to $504.53M in December, reflecting a 80.99% change.

In the past five years, Astria Therapeutics (ATXS) has had a compound annual growth rate (CAGR) of 63.65% in market capitalization. This means its market cap has grown at an average rate of 63.65% per year.

Astria Therapeutics (ATXS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.